Clinical Trial Update: Comparative Evaluation of Oral Ursodeoxycholic Acid in Reducing Bilirubin Levels Among Patients With Acute Viral Hepatitis [NA]

View source ↗

Summary

This clinical trial compares oral ursodeoxycholic acid for reducing bilirubin levels in patients with acute viral hepatitis and is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis E

Drugs mentioned

• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Combined Military Hospital, Pakistan | Conditions: Hepatitis A, Hepatitis E Virus Infection | NA | Status: NOT_YET_RECRUITING